1. Home
  2. UVSP vs PCRX Comparison

UVSP vs PCRX Comparison

Compare UVSP & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Univest Financial Corporation

UVSP

Univest Financial Corporation

HOLD

Current Price

$37.83

Market Cap

983.8M

Sector

Finance

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.23

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVSP
PCRX
Founded
1876
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
983.8M
1.0B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
UVSP
PCRX
Price
$37.83
$25.23
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$36.67
$30.25
AVG Volume (30 Days)
185.3K
411.4K
Earning Date
04-22-2026
04-30-2026
Dividend Yield
2.45%
N/A
EPS Growth
21.32
107.44
EPS
3.13
0.16
Revenue
$328,056,000.00
$541,533,000.00
Revenue This Year
$11.65
$6.78
Revenue Next Year
$4.77
$8.54
P/E Ratio
$12.00
$151.94
Revenue Growth
9.64
26.04
52 Week Low
$27.91
$18.80
52 Week High
$38.71
$27.99

Technical Indicators

Market Signals
Indicator
UVSP
PCRX
Relative Strength Index (RSI) 68.07 61.38
Support Level $32.00 $20.56
Resistance Level N/A $25.23
Average True Range (ATR) 1.03 0.85
MACD 0.04 0.11
Stochastic Oscillator 78.07 90.46

Price Performance

Historical Comparison
UVSP
PCRX

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: